Literature DB >> 19684511

Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis.

Kjell Matthias Kaune1, Mario Baumgart, Hans Peter Bertsch, Christina Mitteldorf, Hans Konrad Müller-Hermelink, Detlef Haase, B Michael Ghadimi, Michael Peter Schön, Christine Neumann.   

Abstract

Blastic plasmacytoid dendritic cell (BPDC) neoplasm, formerly called blastic natural killer cell lymphoma or CD4+/CD56+ hematodermic neoplasm, is a rare tumor entity, now regarded to be derived from the plasmacytoid dendritic cell (PDC) lineage. Because over 90% of patients present with skin lesions usually early in their disease, dermatologists have to be familiar with the specific diagnostic features and the clinical course of this devastating disease. We present a woman with a long standing solitary skin tumor of BPDC neoplasm, who experienced a deleterious clinical course, which is typical for this disease. Phenotypic and karyotypic characteristics distinguishing this tumor from myelomonocytic leukemia with skin involvement are presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684511     DOI: 10.1097/DAD.0b013e3181a5e13d

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  Leukaemia cutis after starting bendamustine: cause or coincidence?

Authors:  Sagger Mawri; Shahzaib Nabi; Bassel Jallad; Joseph Won
Journal:  BMJ Case Rep       Date:  2015-09-21

2.  Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.

Authors:  Iris Amitay-Laish; Uma Sundram; Richard T Hoppe; Emmilia Hodak; Bruno C Medeiros; Youn H Kim
Journal:  JAAD Case Rep       Date:  2017-07-19

3.  Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report.

Authors:  Solomiya Grushchak; Cossette Joy; Arielle Gray; Dan Opel; Jodi Speiser; Jeave Reserva; Rebecca Tung; Scott E Smith
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.